Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.430
-0.040 (-1.62%)
At close: Jul 20, 2026, 4:00 PM EDT
2.440
+0.010 (0.41%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $39.55 million as of July 20, 2026. Its market cap has decreased by -14.96% in one year.
Market Cap
39.55M
Enterprise Value
22.73M
1-Year Change
-14.96%
Ranking
Category
Stock Price
$2.43
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $39.55M, a decrease of -99.42%. That is a compound annual growth rate of -36.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 39.55M | -19.13% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 41.66M |
| Hyperion DeFi | 41.53M |
| PDS Biotechnology | 41.02M |
| Apollomics | 40.67M |
| NanoViricides | 39.87M |
| RenovoRx | 39.02M |
| Veru Inc. | 38.20M |
| Nutriband | 37.81M |